These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib. Mancini M; Corradi V; Petta S; Barbieri E; Manetti F; Botta M; Santucci MA J Pharmacol Exp Ther; 2011 Mar; 336(3):596-604. PubMed ID: 21041536 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Karimiani EG; Marriage F; Merritt AJ; Burthem J; Byers RJ; Day PJ Exp Hematol; 2014 Mar; 42(3):183-191.e5. PubMed ID: 24269846 [TBL] [Abstract][Full Text] [Related]
29. Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells. Oh B; Kim TY; Min HJ; Kim M; Kang MS; Huh JY; Kim Y; Lee DS Anticancer Drugs; 2013 Jan; 24(1):20-31. PubMed ID: 23075630 [TBL] [Abstract][Full Text] [Related]
30. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Shao S; Li S; Qin Y; Wang X; Yang Y; Bai H; Zhou L; Zhao C; Wang C Int J Oncol; 2014 May; 44(5):1661-8. PubMed ID: 24585095 [TBL] [Abstract][Full Text] [Related]
31. The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. Grimaudo S; Meli M; Di Cristina A; Ferro A; Pipitone MR; Romagnoli R; Simoni D; Dieli F; Tolomeo M Anticancer Drugs; 2013 Apr; 24(4):384-93. PubMed ID: 23370613 [TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844 [TBL] [Abstract][Full Text] [Related]
33. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107 [TBL] [Abstract][Full Text] [Related]
34. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition. Niu CC; Zhao C; Yang ZD; Zhang XL; Wu WR; Pan J; Zhao C; Li ZQ; Ding W; Yang Z; Si WK Int J Mol Med; 2013 Feb; 31(2):453-8. PubMed ID: 23233089 [TBL] [Abstract][Full Text] [Related]
36. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells. Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793 [TBL] [Abstract][Full Text] [Related]
37. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation. Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells. Lin TY; Chen KC; Liu HJ; Liu AJ; Wang KL; Shih CM PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340 [TBL] [Abstract][Full Text] [Related]
39. A combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia. Xia DY; Liu L; Hao MW; Liu Q; Chen RA; Liang YM Braz J Med Biol Res; 2014 Dec; 47(12):1096-101. PubMed ID: 25387678 [TBL] [Abstract][Full Text] [Related]
40. The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-α in CML cell line, KT-1 cells. Nishiyama-Fujita Y; Shimizu T; Sagawa M; Uchida H; Kizaki M Leuk Res; 2013 Sep; 37(9):1150-5. PubMed ID: 23759247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]